Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Imiquimod 3.75% cream 250mg sachets
1307000V0AAABAB
|
Imiquimod | Imiquimod | Skin | 609 |
|
ChloraPrep solution 3ml applicators
1311020L0CHAABV
|
ChloraPrep | Chlorhexidine gluconate | Skin | 606 |
|
Canesten 1% solution
1310020H0BBABAA
|
Canesten (Topical) | Clotrimazole | Skin | 604 |
|
Metosyn FAPG 0.05% cream
1304000P0BBAAAA
|
Metosyn | Fluocinonide | Skin | 602 |
|
Siopel cream
1302020D0BEAAAE
|
Siopel | Dimeticone (Barrier) | Skin | 595 |
|
Econazole 1% cream
1310020J0AAAAAA
|
Econazole nitrate (Topical) | Econazole nitrate | Skin | 579 |
|
Locoid 0.1% scalp lotion
1304000W0BBADBB
|
Locoid | Hydrocortisone butyrate | Skin | 578 |
|
Cetrimide 0.2% / Benzalkonium chloride 0.01% cream
1302020B0AAABAB
|
Benzalkonium chloride (Cream) | Benzalkonium chloride | Skin | 577 |
|
Yellow soft paraffin solid
1302010M0AAAAAA
|
Paraffin soft yellow | Paraffin soft yellow | Skin | 566 |
|
Trifarotene 50micrograms/g cream
1306010ACAAAAAA
|
Trifarotene | Trifarotene | Skin | 564 |
|
Trosyl 283mg/ml nail solution
1310020T0BBAAAA
|
Trosyl | Tioconazole | Skin | 562 |
|
Fluticasone 0.05% cream
1304000S0AAAAAA
|
Fluticasone propionate (Topical) | Fluticasone propionate (Topical) | Skin | 553 |
|
Oxytetracycline 3% / Hydrocortisone 1% ointment
1304000V0AACMCM
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 553 |
|
Salicylic acid 50% ointment
1307000M0AAAEAE
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 549 |
|
Urea 5% shampoo
1302010U0AAASAS
|
Urea (Emollient) | Urea | Skin | 549 |
|
Nizoral anti-dandruff 2% shampoo
1309000I0BBAEAA
|
Nizoral (Scalp) | Ketoconazole | Skin | 547 |
|
Fluocinonide 0.05% ointment
1304000P0AABABA
|
Fluocinonide | Fluocinonide | Skin | 532 |
|
Uvistat sun cream SPF 30
130801000BBNSA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 521 |
|
Eumovate Eczema and Dermatitis 0.05% cream
1304000H0BBACAA
|
Eumovate (Topical) | Clobetasone butyrate | Skin | 512 |
|
Dalacin T 1% topical solution
1306010F0BBAAAA
|
Dalacin T | Clindamycin phosphate | Skin | 511 |
|
Dentinox Cradle Cap treatment shampoo
1309000F0BBAAAA
|
Dentinox (Scalp) | Alkyl sulfate | Skin | 510 |
|
Podophyllotoxin 0.15% cream
1307000K0AAABAB
|
Podophyllotoxin | Podophyllotoxin | Skin | 481 |
|
Cetaphil moisturising cream
1311030A0BGADA0
|
Cetaphil | Alkyl sulphate | Skin | 475 |
|
Fluocinonide 0.05% cream
1304000P0AAAAAA
|
Fluocinonide | Fluocinonide | Skin | 472 |
|
Menthoderm 0.5% cream
1303000AABFAAAA
|
Menthoderm | Menthol | Skin | 462 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.